Abstract:Gaofei Ren, 1 Pengfei Jiao, 2 Yushan Yan, 1 Xiaojun Ma, 1 Guijun Qin 1 1 Department of Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China; 2 Department of Respiratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China Correspondence: Xiaojun Ma; Guijun Qin, Department of Endocrinology, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou, 450052, People's Republic of China, Tel +86-0371-66295052, Email ; Background: Inflammation and oxidative stress contribute to the development of diabetic nephropathy (DN). Baicalin (BA) shows renal protection against DN through its anti-inflammatory and anti-oxidant properties. However, the molecular mechanism by which BA exerts the therapeutic effects on DN remains to be investigated. Methods: The db/db mice and high glucose (HG)-induced HK-2 cells were used as the in vivo and in vitro model of DN, respectively. The effects of BA were assessed by detecting the related blood and urine biochemical parameters, kidney histopathology, inflammatory cytokine production, oxidative stress indicators, and apoptosis. Cell viability and apoptosis were detected by CCK-8 assay and TUNEL assay, respectively. Related protein levels were measured by an immunoblotting method. Results: In db/db model mice, BA reduced serum glucose concentration, decreased blood lipid levels, ameliorated kidney functions, and decreased histopathological changes in kidney tissues. BA also alleviated oxidative stress and inflammation in db/db mice. In addition, BA blocked the activation of sphingosine kinases type 1/sphingosine 1-phosphate (SphK1/S1P)/NF-κB pathway in db/db mice. In HK-2 cells, BA hindered HG-induced apoptosis, oxidative stress and inflammation, while overexpression of SphK1 or S1P could reverse these effects. BA alleviated HG-induced apoptosis, oxidative stress and inflammation in HK-2 cells through the S1P/NF-κB pathway. Furthermore, BA blocked the NF-κB signaling by diminishing p65 nuclear translocation via the SphK1/S1P pathway. Conclusion: Our study strongly suggests that BA protects against DN via ameliorating inflammation, oxidative stress and apoptosis through the SphK1/S1P/NF-κB pathway. This study provides a novel insight into the therapeutic effects of BA in DN. Keywords: diabetic nephropathy, baicalin, SphK1/S1P/NF-κB pathway, inflammation, oxidative stress Diabetic nephropathy (DN), the most frequent complication of diabetes mellitus, is the leading cause of end-stage renal disease and is responsible for significantly increased cardiovascular morbidity and mortality worldwide. 1 The pathological mechanisms behind DN progression are multifactorial, including the interactions between oxidation, inflammation, apoptosis, and ultimately fibrosis in the kidney. 2 There is strong evidence that inflammation and oxidative stress are vital risk factors in the occurrence and progression of DN. 3,4 Current treatments can only slow the progression of DN but cannot cure it. 5 Therefore, it is necessary to develop safe and effective drugs to treat DN. 6 Baicalin (BA), a natural flavone glycoside extracted from Scutellaria root, displays multiple pharmacological effects, such as antineoplastic, antimicrobial, antioxidant, and anti-inflammatory activities. 7 BA is reported to exert the protective effects in various human diseases. For instance, BA has been reported as a potent anti-tumor agent for many cancer cell lines by targeting different pathways, such as PI3K/Akt and NF-κB signaling. 8 BA attenuates myocardial ischaemia/reperfusion injury through repressing the JAK/STAT pathway to exert anti-inflammatory activity. 9 BA protects against fluoxetine-induced hepatic injury by repressing inflammation and oxidative stress. 10 BA has also been found to alleviate the progression of DN by relieving podocyte injury, 11 diminishing renal fibrosis, 12 and improving renal function. 13 Moreover, BA exerts a renoprotective role in DN by suppressing inflammation and oxidative stress. 14 However, the molecular basis underlying BA-mediated inhibitory effects on DN remains to be further observed. Sphingosine kinase 1 (SphK1), a lipid kinase responsible for phosphorylating sphingosine into sphingosine-1-phosphate (S1P), can regulate various cellular processes in a variety of pathophysiological conditions, such as cancer, chronic inflammation, and metabolic diseases. 15 The SphK1/S1P signaling pathway has been reported to be dysregulated in numerous pathological and disease s -Abstract Truncated-

Baicalin and Baicalein Attenuate Hyperuricemic Nephropathy Via Inhibiting PI3K/AKT/NF‐κB Signalling Pathway

Baicalin inhibits monosodium urate crystal-induced pyroptosis in renal tubular epithelial cell line through Panx-1/P2X7 pathways: Molecular docking, molecular dynamics, and in vitro experiments

Baicalein Decreases Uric Acid and Prevents Hyperuricemic Nephropathy in Mice

Baicalin - 2- ethoxyethyl ester alleviates renal fibrosis by inhibiting PI3K/AKT/NF-κB signaling pathway

Baicalin Exerts a Protective Effect in Diabetic Nephropathy by Repressing Inflammation and Oxidative Stress Through the SphK1/S1P/NF-κB Signaling Pathway

Baicalin Reduces Renal Inflammation in Mesangial Proliferative Glomerulonephritis Through Activation of Nrf2/ARE and PI3K/AKT Pathways

Baicalin Protects Mice From Aristolochic Acid I-Induced Kidney Injury By Induction Of Cyp1a Through The Aromatic Hydrocarbon Receptor

Baicalin serves a protective role in diabetic nephropathy through preventing high glucose-induced podocyte apoptosis

Baicalein Attenuates Renal Fibrosis by Inhibiting Inflammation Via Down-Regulating NF-κB and MAPK Signal Pathways.

Protective Effects of Baicalin on Diabetes Mellitus-Induced Renal Fibrosis in Mice

Baicalin reversal of DNA hypermethylation-associated Klotho suppression ameliorates renal injury in type 1 diabetic mouse model

Effect of Baicalin on Renal Function in Patients with Diabetic Nephropathy and Its Therapeutic Mechanism

The Effect of Baicalein on the Nf-Kappa B/P65 Expression in the Peripheral Blood of Patients with Diabetic Nephropathy and in Vitro

Baicalin-2-ethoxyethyl ester alleviates gentamicin-induced acute kidney injury via NF-κB signaling pathway

Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase

Baicalin and baicalein attenuate renal fibrosis in vitro via inhibition of the TGF-β1 signaling pathway

Kidney-targeted baicalin-lysozyme conjugate ameliorates renal fibrosis in rats with diabetic nephropathy induced by streptozotocin

Baicalin Targets HSP70/90 to Regulate PKR/PI3K/AKT/eNOS Signaling Pathways

Baicalein Ameliorates Renal Interstitial Fibrosis by Inducing Myofibroblast Apoptosis in Vivo and in Vitro.

Baicalein Acts As A Nephroprotectant That Ameliorates Colistin-Induced Nephrotoxicity by Activating the Antioxidant Defence Mechanism of the Kidneys and Down-Regulating the Inflammatory Response

Baicalein alleviates tubular-interstitial nephritis in vivo and in vitro by down-regulating NF-κB and MAPK pathways